Literature DB >> 16455923

Use of a new dual-antigen enzyme-linked immunosorbent assay to detect and characterize the human antibody response to the human immunodeficiency virus type 2 envelope gp125 and gp36 glycoproteins.

José Maria Marcelino1, Helena Barroso, Fátima Gonçalves, Sofia Marques Silva, Carlos Novo, Perpétua Gomes, Ricardo Camacho, Nuno Taveira.   

Abstract

A dual-antigen enzyme-linked immunosorbent assay specific for human immunodeficiency virus type 2 (HIV-2) envelope proteins, ELISA-HIV2, was developed with two new recombinant polypeptides, rpC2-C3 and rgp36, derived from the HIV-2 envelope. The diagnostic performance was determined with HIV-2, HIV-1, and HIV-1/2 samples. Both polypeptides showed 100% specificity. Clinical sensitivity was 100% for rgp36 and 93.4% for rpC2-C3. ELISA-HIV2 may be used for the specific diagnosis and confirmation of HIV-2 infection.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16455923      PMCID： PMC1392652          DOI： 10.1128/JCM.44.2.607-611.2006

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  46 in total

Review 1.  Towards a better understanding of the epidemiology of HIV-2.

Authors:  M F Schim van der Loeff; P Aaby
Journal:  AIDS       Date:  1999       Impact factor: 4.177

2.  Comparative evaluation of eight commercial enzyme linked immunosorbent assays and 14 simple assays for detection of antibodies to HIV.

Authors:  G Beelaert; G Vercauteren; K Fransen; M Mangelschots; M De Rooy; S Garcia-Ribas; Guido van der Groen
Journal:  J Virol Methods       Date:  2002-09       Impact factor: 2.014

3.  Synthetic peptide strategy for the detection of and discrimination among highly divergent primate lentiviruses.

Authors:  F Simon; S Souquière; F Damond; A Kfutwah; M Makuwa; E Leroy; P Rouquet; J L Berthier; J Rigoulet; A Lecu; P T Telfer; I Pandrea; J C Plantier; F Barré-Sinoussi; P Roques; M C Müller-Trutwin; C Apetrei
Journal:  AIDS Res Hum Retroviruses       Date:  2001-07-01       Impact factor: 2.205

4.  Seven human immunodeficiency virus (HIV) antigen-antibody combination assays: evaluation of HIV seroconversion sensitivity and subtype detection.

Authors:  T D Ly; L Martin; D Daghfal; A Sandridge; D West; R Bristow; L Chalouas; X Qiu; S C Lou; J C Hunt; G Schochetman; S G Devare
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

5.  Serum immunoglobulin A (IgA)-mediated immunity in human immunodeficiency virus type 2 (HIV-2) infection.

Authors:  Qin Lizeng; Pia Skott; Samer Sourial; Charlotta Nilsson; Sören Andersson S; Mariethe Ehnlund; Nuno Taveira; Ewa Björling
Journal:  Virology       Date:  2003-04-10       Impact factor: 3.616

6.  Fourth-generation enzyme-linked immunosorbent assay for the simultaneous detection of human immunodeficiency virus antigen and antibody.

Authors:  R D Saville; N T Constantine; F R Cleghorn; N Jack; C Bartholomew; J Edwards; P Gomez; W A Blattner
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

7.  Comparing modified and plain peptide linked enzyme immunosorbent assay (ELISA) for detection of human immunodeficiency virus type-1 (HIV-1) and type-2 (HIV-2) antibodies.

Authors:  M Manocha; K T Chitralekha; M Thakar; D Shashikiran; R S Paranjape; D N Rao
Journal:  Immunol Lett       Date:  2003-02-03       Impact factor: 3.685

8.  Evaluation of a new combined antigen and antibody human immunodeficiency virus screening assay, VIDAS HIV DUO Ultra.

Authors:  Bernard Weber; Annemarie Berger; Holger Rabenau; Hans Wilhelm Doerr
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

9.  Dual infections with HIV-1, HIV-2 and HTLV-I are more common in older women than in men in Guinea-Bissau.

Authors:  Birgitta Holmgren; Zacarias da Silva; Olav Larsen; Pernille Vastrup; Sören Andersson; Peter Aaby
Journal:  AIDS       Date:  2003-01-24       Impact factor: 4.177

10.  Antigenic conservation and immunogenicity of the HIV coreceptor binding site.

Authors:  Julie M Decker; Frederic Bibollet-Ruche; Xiping Wei; Shuyi Wang; David N Levy; Wenquan Wang; Eric Delaporte; Martine Peeters; Cynthia A Derdeyn; Susan Allen; Eric Hunter; Michael S Saag; James A Hoxie; Beatrice H Hahn; Peter D Kwong; James E Robinson; George M Shaw
Journal:  J Exp Med       Date:  2005-05-02       Impact factor: 14.307
View more
  6 in total

1.  Potent and broadly reactive HIV-2 neutralizing antibodies elicited by a vaccinia virus vector prime-C2V3C3 polypeptide boost immunization strategy.

Authors:  José Maria Marcelino; Pedro Borrego; Cheila Rocha; Helena Barroso; Alexandre Quintas; Carlos Novo; Nuno Taveira
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

2.  Inexpensive designer antigen for anti-HIV antibody detection with high sensitivity and specificity.

Authors:  Sheikh M Talha; Teppo Salminen; Deepti A Chugh; Sathyamangalam Swaminathan; Tero Soukka; Kim Pettersson; Navin Khanna
Journal:  Clin Vaccine Immunol       Date:  2010-01-20

3.  Evolutionary and structural features of the C2, V3 and C3 envelope regions underlying the differences in HIV-1 and HIV-2 biology and infection.

Authors:  Helena Barroso; Pedro Borrego; Inês Bártolo; José Maria Marcelino; Carlos Família; Alexandre Quintas; Nuno Taveira
Journal:  PLoS One       Date:  2011-01-20       Impact factor: 3.240

4.  Low Postseroconversion CD4+ T-cell Level Is Associated with Faster Disease Progression and Higher Viral Evolutionary Rate in HIV-2 Infection.

Authors:  Joakim Esbjörnsson; Patrik Medstrand; Angelica A Palm; Philippe Lemey; Marianne Jansson; Fredrik Månsson; Anders Kvist; Zsófia Szojka; Antonio Biague; Zacarias José da Silva; Sarah L Rowland-Jones; Hans Norrgren
Journal:  mBio       Date:  2019-01-08       Impact factor: 7.867

5.  HIV-2 and its role in conglutinated approach towards Acquired Immunodeficiency Syndrome (AIDS) Vaccine Development.

Authors:  Batul Diwan; Rupali Saxena; Archana Tiwari
Journal:  Springerplus       Date:  2013-01-11

6.  The role of the humoral immune response in the molecular evolution of the envelope C2, V3 and C3 regions in chronically HIV-2 infected patients.

Authors:  Pedro Borrego; José Maria Marcelino; Cheila Rocha; Manuela Doroana; Francisco Antunes; Fernando Maltez; Perpétua Gomes; Carlos Novo; Helena Barroso; Nuno Taveira
Journal:  Retrovirology       Date:  2008-09-08       Impact factor: 4.602
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.